To determine whether TPX2 clinically correlated with colon cancer progression, the expression of TPX2 was determined by immunohistochemistry in a tissue microarray containing 203 cases of primary colon cancer paired with their non-cancerous tissue and 66 lymph node metastases (LNM). Here, TPX2 is linked to malignant colon neoplasm.